NIH-funded research R01 grant

Investigating treatments for vision loss in familial dysautonomia.

Official title: Optic neuropathy in familial dysautonomia: determination of disease mechanisms and functional rescue.

Funded at Schepens Eye Research Institute · NIH-11049740 · Data updated 2026-11-12

This study is looking for new ways to help people with familial dysautonomia, a condition that can cause vision loss, by testing different treatments to see which ones might help restore sight.

More Neuropathy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSchepens Eye Research Institute
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$638,267
NIH project number1R01EY036009-01A1
Project IDNIH-11049740 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with familial dysautonomia who are experiencing vision loss.

Less likely to help

Patients without familial dysautonomia or those whose vision loss is due to other causes may not benefit from this research.

What this research studies

This research focuses on familial dysautonomia, a neurodegenerative disorder that leads to progressive blindness due to the loss of retinal ganglion cells. The study aims to develop a targeted treatment for this condition by evaluating both systemic and local therapeutic approaches to restore visual function. Researchers will conduct detailed assessments of the retina's cellular and visual functions using advanced testing methods. By comparing the effectiveness of different treatment strategies, the research seeks to enhance our understanding of the disease and its impact on vision.

Why it matters

Potential benefit: If successful, this research could lead to effective treatments that restore vision and improve the quality of life for patients with familial dysautonomia.

How similar studies have gone: Previous studies have shown promise in using genetic and pharmacological approaches to rescue retinal function, indicating potential success for this research.

Where this research is happening

  • Schepens Eye Research Institute
    Boston, United States
    Active

Researchers

  • Principal investigator: Chekuri, Anil K. — Schepens Eye Research Institute
  • Study coordinator: Chekuri, Anil K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.